Literature DB >> 8390764

HSV-1 activation of HIV-1 transcription is augmented by a cellular protein that binds near the initiator element.

D M Margolis1, J M Ostrove, S E Straus.   

Abstract

A cellular DNA binding protein, which we term Leader Binding Protein-2 (LBP-2), binds near the transcriptional initiation site of the human immunodeficiency virus type 1 (HIV-1) promoter. This protein recognizes a motif similar to that of LBP-1, a putative repressor of transcription (Kato, H., et al., Science, 251, 1476-1479, 1991). LBP-2 is associated with transcriptional activation of HIV-1 by herpes simplex virus type 1 (HSV-1). Electrophoretic mobility shift assays showed that nuclear levels of this protein increase markedly following HSV-1 infection. Mutations of the LBP binding motif eliminate LBP-2 binding and interfere with HIV-1 activation by HSV-1. When inserted into an unrelated promoter, this motif confers transcriptional responsiveness to HSV-1 infection. Proteins that bind near the initiator element may be important regulators of HIV-1 gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390764     DOI: 10.1006/viro.1993.1046

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

Review 1.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

Review 2.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

3.  The herpes simplex virus type 1 major capsid protein (VP5-UL19) promoter contains two cis-acting elements influencing late expression.

Authors:  C J Huang; E K Wagner
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

4.  Mitogen-activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter.

Authors:  Loyda Ylisastigui; Rupinderjeet Kaur; Holly Johnson; Janet Volker; Guocheng He; Ulla Hansen; David Margolis
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1 provirus.

Authors:  J Vlach; P M Pitha
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production.

Authors:  D M Margolis; M Somasundaran; M R Green
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.

Authors:  S L Schafer; J Vlach; P M Pitha
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.

Authors:  Clare Tanton; Helen A Weiss; Mary Rusizoka; Jerome Legoff; John Changalucha; Kathy Baisley; Kokugonza Mugeye; Dean Everett; Laurent Belec; Tim C Clayton; David A Ross; Richard J Hayes; Deborah Watson-Jones
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.